Hej jeg er ny her på ProInvestor, hvor finder man en tråd om Veloxis som går helt grasat op ad i disse dage. Er der nogen som har et langsigtet target på den.
6/11 2019 13:12 Helge Larsen/PI-redaktør 1
78844 Du kan følge her.
https://www.proinvestor.com/chathistory/-103/veloxis
https://www.proinvestor.com/chathistory/-103/veloxis
6/11 2019 18:54 msn 078870 Prøver lige igen, da der er flere som spørg om det sammen.
Hvad er forskellen på AVA 1,2, 3
omxnews:
Trading Halt: Order Book MINI L VELOXIS AVA 2 in market STO Warrants at 17:05:00.086
TAK
Hvad er forskellen på AVA 1,2, 3
omxnews:
Trading Halt: Order Book MINI L VELOXIS AVA 2 in market STO Warrants at 17:05:00.086
TAK
Shareholders
Name Equities %
Novo Nordisk Fonden 707,896,475 40.7%
Lundbeck Foundation 707,896,475 40.7%
Zürcher Kantonalbank (Investment Management) 3,826,861 0.22%
Investec Asset Management Ltd. 3,330,839 0.19%
Capital Research & Management Co. (World Investors) 2,065,913 0.12%
Danske Bank A/S (Investment Management) 1,938,535 0.11%
Keskinäinen Työeläkevakuutusyhtiö Varma 896,100 0.052%
Xact Kapitalförvaltning AB 700,019 0.040%
Lån & Spar Bank A/S (Investment Management) 629,577 0.036%
Skandinaviska Enskilda Banken AB (Denmark) 469,144 0.027%
Name Equities %
Novo Nordisk Fonden 707,896,475 40.7%
Lundbeck Foundation 707,896,475 40.7%
Zürcher Kantonalbank (Investment Management) 3,826,861 0.22%
Investec Asset Management Ltd. 3,330,839 0.19%
Capital Research & Management Co. (World Investors) 2,065,913 0.12%
Danske Bank A/S (Investment Management) 1,938,535 0.11%
Keskinäinen Työeläkevakuutusyhtiö Varma 896,100 0.052%
Xact Kapitalförvaltning AB 700,019 0.040%
Lån & Spar Bank A/S (Investment Management) 629,577 0.036%
Skandinaviska Enskilda Banken AB (Denmark) 469,144 0.027%
7/11 2019 14:08 msn 078909 flere oplysninger: Ownership Structure
As at 31 December 2018, a total of
8,723 of Veloxis's shareholders were
registered in the shareholder register;
an increase from 8,040 shareholders
as at 31 December 2017. Veloxis
invites all shareholders to register in
the Company's shareholder register.
As at 31 December 2018, the following
shareholders have reported ownership of
5% or more of the Company's shares:
• Lundbeckfond Invest A/S 41.2%
(100% owned by the Lundbeck
Foundation), Denmark, municipality
of Copenhagen
• Novo Holdings A/S 41.2% (100%
owned by the Novo Nordisk
Foundation), Denmark, municipality
of Gentofte.Number of shares held by Alta Partners:Nov 7, 2019 12:41 PM CET
Alta BioPharma Partners III, L.P 25,988,848 shares
Alta BioPharma Partners III, GmbH & Co. Beteiligungs KG 1,745,432 shares
Alta Embarcadero BioPharma Partners III, LLC 640,440 shares
28,374,720 shares
Alta Partners consequently, directly and indirectly, holds 28,374,720 shares in Veloxis Pharmaceuticals A/S with a nominal value of DKK 0.1 each, equivalent to 1.71 % of the share capital and the voting rights.
Passer ikke helt efter den lille tabel.
As at 31 December 2018, a total of
8,723 of Veloxis's shareholders were
registered in the shareholder register;
an increase from 8,040 shareholders
as at 31 December 2017. Veloxis
invites all shareholders to register in
the Company's shareholder register.
As at 31 December 2018, the following
shareholders have reported ownership of
5% or more of the Company's shares:
• Lundbeckfond Invest A/S 41.2%
(100% owned by the Lundbeck
Foundation), Denmark, municipality
of Copenhagen
• Novo Holdings A/S 41.2% (100%
owned by the Novo Nordisk
Foundation), Denmark, municipality
of Gentofte.Number of shares held by Alta Partners:Nov 7, 2019 12:41 PM CET
Alta BioPharma Partners III, L.P 25,988,848 shares
Alta BioPharma Partners III, GmbH & Co. Beteiligungs KG 1,745,432 shares
Alta Embarcadero BioPharma Partners III, LLC 640,440 shares
28,374,720 shares
Alta Partners consequently, directly and indirectly, holds 28,374,720 shares in Veloxis Pharmaceuticals A/S with a nominal value of DKK 0.1 each, equivalent to 1.71 % of the share capital and the voting rights.
Passer ikke helt efter den lille tabel.
